Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,316 | 38,615 | 51,665 | 68,467 | 80,125 |
| Marketable Securities | 21,802 | 14,152 | 14,710 | 12,006 | 16,824 |
| Receivables | 12 | 3 | 10 | 39 | 163 |
| Other current assets | 1,060 | 1,014 | 819 | 911 | 1,698 |
| TOTAL | $58,190 | $53,784 | $67,204 | $81,423 | $98,810 |
| Non-Current Assets | |||||
| PPE Net | 3,395 | 4,183 | 5,075 | 6,191 | 77,309 |
| Investments And Advances | 6,602 | 21,242 | 19,609 | 21,057 | 21,255 |
| Other Non-Current Assets | 7,721 | 7,660 | 9,140 | 9,511 | 10,359 |
| TOTAL | $17,718 | $33,085 | $33,824 | $36,759 | $108,923 |
| Total Assets | $75,908 | $86,869 | $101,028 | $118,182 | $207,733 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 276 |
| Accounts payable and accrued liabilities | 1,501 | 1,752 | 2,551 | 1,599 | 2,988 |
| Accrued Expenses | 7,870 | 10,104 | 9,056 | 10,905 | 12,785 |
| TOTAL | $24,044 | $33,017 | $32,536 | $26,094 | $18,975 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,775 | 5,747 | 5,727 | 5,720 | 2,926 |
| Other Non-Current Liabilities | 2,204 | 2,102 | 3,268 | 3,244 | 3,961 |
| TOTAL | $50,789 | $46,504 | $49,381 | $55,314 | $125,111 |
| Total Liabilities | $74,833 | $79,521 | $81,917 | $81,408 | $144,086 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,207 | 39,090 | 39,055 | 38,674 | 38,598 |
| Common Shares | 39 | 39 | 39 | 39 | 39 |
| Retained earnings | -746,385 | -738,208 | -722,928 | -703,263 | -674,409 |
| Other shareholders' equity | 1,243 | 1,038 | -1,438 | -1,570 | -1,744 |
| TOTAL | $1,075 | $7,348 | $19,111 | $36,774 | $63,647 |
| Total Liabilities And Equity | $75,908 | $86,869 | $101,028 | $118,182 | $207,733 |